SCHEMBL7057774

SCHEMBL7057774

OC1COCC(c2cccc3ccccc23)O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A3 Q01959 2/20 0.47
KDM1A O60341 1/20 0.41
EPHX1 P07099 1/20 0.41
MTNR1A P48039 2/20 0.36
MTNR1B P49286 1/20 0.36
GSK3B P49841 1/20 0.36
ADK P55263 1/20 0.36
IDO1 P14902 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TDP2 O95551 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP3 P42574 1/20 0.35
HTT P42858 1/20 0.35
GALK1 P51570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10300820 0.75 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL2464189 0.75 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL5852684 0.75 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL30360438 0.75 SLC6A4 (0.46) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
Methyl Alcohol SCHEMBL8766877 0.74 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL3073148 0.73 SLC6A4 (0.45) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL25338654 0.73 MTNR1A (0.50) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL5699413 0.72 SLC6A4 (0.50) SLC6A4SLC6A2SLC6A3KDM1AEPHX1
SCHEMBL13116598 0.70 ADRA2A (0.41)
SCHEMBL29137625 0.69 SLC6A4 (0.44) SLC6A4SLC6A2SLC6A3KDM1AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608215-B2 Photochromic ophthalmic or sun protection lenses, glass paneling VISION-EASE LENS, INC. 2003-08-19 US disclosed
US-20030092918-A1 Oxygen-containing heterocyclic fused naphthopyrans VISION-EASE LENS, INC. 2003-05-15 US disclosed
WO-2003025638-A1 OXYGEN-CONTAINING HETEROCYCLIC FUSED NAPHTHOPYRANS VISION-EASE LENS, INC. (US) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092918-A1 Oxygen-containing heterocyclic fused naphthopyrans NQO1, NFE2L2, NDUFV2 SLC6A4 4503/4885SLC6A2 4347/4885SLC6A3 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.